Natural Products Insider

The Omega-3 Clinical Study Database, now in phase 2 data extraction, will one day be a searchable database of human clinical trials that examined the effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), or the combination of those two long-chain omega-3s. GOED (The Global Organization for EPA and DHA Omega-3s) started this endeavor two years ago, as Ellen Schutt, executive director, explains in this Healthy Insider Podcast, and has narrowed down 35,000 potential studies into 4,000 specifically focused on EPA/DHA that need to be categorized for demographics, dosage, intervention and outcome.